Related Experiment Video

Updated: Aug 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signaling

Kideok Jin1, Seunghwan Lim, Stephen E Mercer

  • 1Department of Pathology, State University of New York, Upstate Medical University, Syracuse, New York 13210, USA.

The Journal of Biological Chemistry
|November 1, 2005
PubMed

Insights

The serine/threonine kinase Mirk/dyrk1B is activated by Rac1 signaling to MKK3, a pathway crucial for cell survival in tumors. This discovery reveals a new anti-apoptotic signaling mechanism involving Mirk kinase in human cancers.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • The serine/threonine kinase Mirk/dyrk1B is implicated in cell survival in various solid tumors.
  • The precise mechanism of Mirk kinase activation within tumor cells remains largely unknown.
  • Rac1, a Ras superfamily GTPase, promotes cell survival and transformation downstream of Ras oncoproteins.

Purpose of the Study:

  • To elucidate the signaling pathway responsible for Mirk kinase activation in tumor contexts.
  • To investigate the role of Rac1 and MKK3 in the activation of Mirk kinase.
  • To characterize a novel anti-apoptotic signaling pathway linking Rac1 to Mirk kinase.

Main Methods:

  • Utilized constitutively active and dominant-negative Rac1 mutants.
  • Employed RNA interference to knockdown MKK3 expression.
  • Investigated Mirk kinase activity in Madin-Darby canine kidney (MDCK) epithelial cells following E-cadherin ligation.
  • Assessed Rac1 activity and Mirk activation in response to E-cadherin engagement and Rac1 inhibition.

Main Results:

  • Demonstrated that Rac1 activates Mirk kinase through the mitogen-activated protein kinase kinase MKK3.
  • Showed that MKK3 phosphorylates and activates Mirk kinase.
  • Confirmed that inhibition of Rac1 or MKK3, or MKK3 knockdown, reduces Mirk kinase activity.
  • Observed Mirk activation by endogenous Rac1 upon E-cadherin ligation in MDCK cells.
  • Found that disruption of cadherin ligation inhibits Mirk activation.

Conclusions:

  • Established a novel signaling pathway where Rac1 activates Mirk kinase via MKK3.
  • This Rac1-MKK3-Mirk pathway represents a new mechanism for promoting cell survival and evading apoptosis in tumors.
  • Mirk kinase is identified as a novel downstream effector of Rac1-mediated survival signals in human cancers.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...